Tweet You can see Neil's latest speeches and appearances in Parliament below (provided by theyworkforyou):
HIV Infection: Drugs | Department of Health and Social Care | Written Answers The HIV Action Plan sets out continued investment in pre-exposure prophylaxis (PrEP) through the Public Health Grant and to develop a plan t
Life Expectancy: Portsmouth South | Department of Health and Social Care | Written Answers No specific assessment has been made.
Healthy Start Scheme | Department of Health and Social Care | Written Answers The NHS Business Services Authority promotes the Healthy Start scheme through its digital channels and has created free tools for stakeholde
Electronic Cigarettes: Secondary Education | Department of Health and Social Care | Written Answers NHS Digital’s ‘Smoking, Drinking and Drug Use among Young People in England, 2021’ published in September 2022, shows that current regular a
Coronavirus: Disease Control | Department of Health and Social Care | Written Answers ‘COVID-19 Response: Living with COVID-19’, published in February, set out how COVID-19 will be managed in the same way as other respiratory
Health Services: Power Failures | Department of Health and Social Care | Written Answers The Department is working with the health and social care sector to understand the impact of any disruption to energy on services and with t
Health: Portsmouth South | Department of Health and Social Care | Written Answers ‘Our plan for patients’, published on 22 September, sets out the immediate priorities to support individuals to live healthier lives, includ
Coronavirus: Vaccination | Department of Health and Social Care | Written Answers The post-authorisation conditions relating to any Conditional Marketing Authorisations (CMA) are only removed from the licence once these co
Malnutrition: Portsmouth South | Department of Health and Social Care | Written Answers No specific assessment has been made.
Palivizumab | Department of Health and Social Care | Written Answers Following a letter from clinicians, the Joint Committee on Vaccination and Immunisation (JCVI) requested that the Palivizumab National Exper